Watch | Coronavirus Updates, April 24: Leaked Study Shows Remdesivir Ineffective Against COVID-19
Pawanjot Kaur
Real journalism holds power accountable
Since 2015, The Wire has done just that.
But we can continue only with your support.
The results of the clinical trials conducted on Remdesivir, the antiviral by Gilead Sciences shows that the drug fails to speed the improvement of patients with COVID-19 and doesn’t not prevent them from dying. The results of this clinical trial were long-awaited.
A US company Gilead Sciences, however, has said that the data suggest that there is a “potential benefit.”
According to reports, a draft document was accidentally posted on the website of the WHO and was removed later. It is unclear why this was done
Gilead spokesperson Amy Flood told the media that according to the company, the post on WHO’s website mischaracterised the study.
The Wire is now on WhatsApp. Follow our channel for sharp analysis and opinions on the latest developments.